| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |